Optimisation of sampling windows design for population pharmacokinetic experiments.

Area of Science:

• Pharmacokinetics
• Drug Development
• Statistical Modeling

Background:

• Population pharmacokinetic (PK) studies are crucial in late-phase drug development.
• Uncontrolled environments in multi-center and out-patient settings can lead to problematic sample collection and uninformative data.
• Existing sampling designs may lack the flexibility needed for practical application.

Purpose of the Study:

• To develop and optimize sampling windows for population pharmacokinetic experiments.
• To enhance the efficiency and practicality of sample collection in real-world clinical settings.
• To provide flexibility in sample timing while ensuring satisfactory parameter estimation.

Main Methods:

• An optimization approach using prior experimental data (model and parameter estimates).
• Optimization within a defined space of admissible sampling windows sequences.
• Continuous design optimization including sampling windows and population design structure (subject proportions, number of designs, windows per design).

Main Results:

• Optimal sampling windows designs are highly efficient for estimating population PK parameters.
• The proposed approach offers significant flexibility in sample collection timing.
• The generalized equivalence theorem was confirmed to hold for this optimization method.

Conclusions:

• The developed approach provides efficient and flexible sampling window designs for population pharmacokinetic studies.
• This method is particularly beneficial for late-phase drug development and complex clinical settings.
• The optimization strategy ensures robust parameter estimation and validates theoretical principles.